$TGTX upturn Pr $6.34
TG Therapeutics Announces Orphan
$TGTX upturn Pr $6.34
TG Therapeutics Announces Orphan Drug Designation
for TG-1101 for the Treatment of Neuromyelitis Optica
and Neuromyelitis Optica Spectrum Disorder
Website
Float 26.82M
% Held by Insiders 49.75%
% Held by Institutions 1 35.10%
Shares Short 7.24M
Short Ratio 22.93
Short % of Float 24.14%
Shares Short (prior month) 7.54M
TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. It develops TG-1101 (ublituximab), a novel glycol engineered monoclonal antibody that targets a epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory non-Hodgkins lymphoma and chronic lymphocytic leukemia. The company also develops TGR-1202, an orally available phosphoinositide-3-kinase delta inhibitor with nanomolar potency to the delta isoform and high selectivity over the alpha, beta, and gamma isoforms, as well as for hematologic malignancies. In addition, it develops a pre-clinical program to develop the inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4); and anti-PD-L1 and anti-GITR antibody research programs that are in pre-clinical development stage in the field of hematological malignancies. The company has license agreements with LFB Biotechnologies S.A.S, GTC Biotherapeutics, LFB/GTC LLC, and Ildong Pharmaceutical Co. Ltd. for the development and commercialization of TG-1101; Rhizen Pharmaceuticals, SA for the development and commercialization of TGR-1202; and Ligand Pharmaceuticals Incorporated for the development and commercialization of IRAK4 inhibitor technology. It also has a collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. is headquartered in New York, New York.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...
Continue Reading
A billion dollars of fresh paper just landed on Restaurant Brands International’s balance-sheet doorstep, and this one deserves more than the usual sleepy glance at a financing release. RBI has priced $500 million of 6.00% senior secured notes due 2031 and another $500 million of 6.40% senior secured notes due 2036. The expected closing date is November 24, 2026,...
Continue Reading
AI Surge Demands Cooler Solutions Alright, who'd guess that data centers would feel the heat—literally—like a welder's furnace in Abu Dhabi? As AI demand burns hotter across the Middle East, data centers are sweating it out against 50°C-plus temperatures. We're talking about some serious pressure on traditional cooling methods that just can’t cut it anymore....
Continue Reading
Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...
Continue Reading
A flooded quarry pit outside Cortlandville is getting a second career, and that is more interesting than another solar announcement draped across empty acreage. Third Pillar Power has started construction on Crown City Solar at Suit-Kote Corporation's active Polkville Crushed Stone Facility, pairing a working mine, asphalt plant, and storage terminal with what the...
Continue Reading
Cross-border payouts have always had an ugly little problem: money can move digitally in theory, then sit around waiting for banks to wake up in practice. Triple-A’s new collaboration with Visa Direct aims straight at that nuisance in Asia-Pacific, allowing eligible clients to use stablecoins to prefund cross-border payouts while the recipient still gets local currency....
Continue Reading
Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...
Continue Reading
Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...
Continue Reading
A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...
Continue Reading
Brazilian clinical-trial kit deliveries may soon spend less time tangled in international shipping. That is the practical heart of Labcorp's newly announced collaboration with Grupo Fleury, and frankly, practical is plenty good in this business. Labcorp plans to begin assembling clinical-trial kits locally in Brazil in early 2027, then add laboratory operations by the end...
Continue Reading
Top 5 Most Recently Viewed Articles
Nokia and Microscan Join Forces for Optical Network Enhancement Nokia and Microscan have teamed up to create a high-capacity metro and regional optical network in Western India, marking a significant advancement in regional connectivity. This collaboration targets boosting bandwidth and improving overall network reliability for a variety of customers, including...
Continue Reading
Southland Holdings Enters $160 Million Credit Facility Southland Holdings, Inc. (NYSE American: SLND and SLND WS), recognized as a leader in specialized infrastructure construction services, has successfully closed a new senior secured credit facility valued at $160 million. This new financial arrangement includes an initial draw term loan of $140 million and a delayed...
Continue Reading
Introducing the ezPaycheck Network Version for Businesses The ezPaycheck payroll software has released its 2025 network version, aimed at enhancing productivity for growing companies and remote workers. This update brings numerous advantages, ensuring businesses can efficiently manage payroll, regardless of where their team operates. Key Features of the ezPaycheck Network...
Continue Reading
Profit Spike Fueled by Strategic Moves Amid an insipid global tire market shaking with economic jitters, Nokia’s own Nokian Tyres somehow pulled a rabbit out of a hat. If this isn’t proof that strategy and perseverance pay off, what else is? This Finnish giant just rolled in with earnings that shout, 'We’re doing something right!' Let’s break down how they fared...
Continue Reading
CGI Partners with Wounded Warrior Project to Help Veterans CGI (TSX: GIB.A) (NYSE: GIB), a leader in IT and business consulting, is proud to announce its collaboration with the Wounded Warrior Project to develop MyWWP, a robust digital portal dedicated to supporting wounded veterans and their families. This enhanced online platform is designed to connect users with...
Continue Reading